EQL Pharma AB (publ) (STO:EQL)
Sweden
· Delayed Price · Currency is SEK 85.50
+0.10 (0.12%)
At close: Aug 13, 2025
EQL Pharma AB Market Cap
EQL Pharma AB has a market cap or net worth of 2.48 billion as of August 14, 2025. Its market cap has increased by 58.33% in one year.
Market Cap
2.48B
Enterprise Value
2.88B
Revenue
397.94M
Ranking
n/a
PE Ratio
60.60
Stock Price
85.50
Market Cap Chart
Since December 17, 2013, EQL Pharma AB's market cap has increased from 78.22M to 2.48B, an increase of 3,076.77%. That is a compound annual growth rate of 34.52%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 94.08B |
| Sectra AB | 67.67B |
| Getinge AB | 54.11B |
| Medicover AB | 40.69B |
| Asker Healthcare Group AB | 39.30B |
| Camurus AB | 38.09B |
| Bonesupport Holding AB | 20.44B |
| AddLife AB | 20.06B |